ODI Pharma AB (publ)Stockholm
LEI 8945001MNHCQFIP27M14 · XSTO · SE · Business ID 559223-1392
Recent insider sentiment
No open-market buying or selling — last 90 days
Share-award batches are excluded from this read — they’re compensation, not conviction.
0
Open-market buys (90d)
0
Sales (90d)
0
Share awards (90d)
0
Active insiders (90d)
Transactions
| Date | Person | Nature | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 08.01.2026 | Johan Edewaard — CEO | Bought — open marketAcquisition | 10,000 | SEK 3.76 | SEK 37,600.00 | ↗ |
| 05.01.2026 | Johan Edewaard — CEO | Bought — open marketAcquisition | 3,471 | SEK 3.00 | SEK 10,413.00 | ↗ |
Active insiders (90d)
No activity in the last 90 days.